Research Highlights

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a computational approach to make drug discovery faster and less expensive while also being safe and effective.

Albert H. Titus, PhD, has been elected a fellow of the National Academy of Inventors (NAI).

Cytocybernetics, the UB spinoff co-founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, is aiding in the effort to clear candidate drug therapies for COVID-19 in a fast, effective and safe manner.

Manoj J. Mammen, MD, associate professor of medicine in the Division of Pulmonary, Critical Care and Sleep Medicine, is one of the co-authors of new clinical practice guidelines for chronic obstructive pulmonary disease (COPD) issued by the American Thoracic Society.

Jennifer A. Surtees, PhD, associate professor of biochemistry, is leading an effort to track the genomics of COVID-19 in Western New York.

The findings from a recent study by a Jacobs School of Medicine and Biomedical Sciences researcher and others could prove to be a game-changer for men with Type 2 diabetes and the syndrome of hypogonadism.

Two studies by Asher Weiner, MD, could help increase safety and minimize expense for patients undergoing glaucoma surgery.

New research reveals for the first time that despite the fragility of axons, Schwann cells — which surround axons within nerves like a glove covers a hand — can come to the assistance of injured axons.

Research by Steven J. Fliesler, PhD, has revealed important new information about the possible cause of a rare form of irreversible blindness in young children.  

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a method that dramatically ramps up production of mature human cells in mouse embryos.